Net Cash Provided by (Used in) Operating Activities |
-15.2K |
USD |
-8.71% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
13.6K |
USD |
-2.82% |
Q4 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
190M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
5.28M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-13 |
USD |
-101% |
Q4 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.45K |
USD |
+50.3% |
Q2 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
48.6K |
USD |
+25.2% |
Q3 2023 |
FY 2023 |
Property, Plant and Equipment, Gross |
5.3K |
USD |
0% |
Q3 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
48.6K |
USD |
+25.2% |
Q3 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Additional Paid in Capital |
99.2K |
USD |
0% |
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
102 |
USD |
|
Q4 2022 |
Q1 2024 |
Interest Expense |
1.15K |
USD |
+47.9% |
Q2 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |